Actively Recruiting
NGS in Gallbladder Cancer and Response to Treatment
Led by Banaras Hindu University · Updated on 2024-08-13
100
Participants Needed
1
Research Sites
469 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Evidence suggests distinct models of molecular and pathologic progression, and a growing body of genetics data points to a heterogeneous collection of underlying mutations in key oncogenes and tumor suppressor genes. Although tumor genetics have been used to tailor individual treatment regimens and guide clinical decision making in other cancers, these principles have not been applied in gallbladder malignancy. Recent clinical trials with targeted therapies seem promising, although the relationships between subsets of patients with positive responses to therapy and tumor genetics remain unexplored.
CONDITIONS
Official Title
NGS in Gallbladder Cancer and Response to Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Treatment naive patients with histologically proven carcinoma of the gallbladder.
You will not qualify if you...
- No histological evidence of malignancy
- Pregnant and lactating women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Banaras Hindu University
Varanasi, Uttar Pradesh, India, 221005
Actively Recruiting
Research Team
M
Manoj Pandey, MS, PhD
CONTACT
S
S K Singh, MD, DM
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here